IBACR: Blank Check Firm Hunts $500M+ Target Amid 2026 Deadline

TL;DR

**IBACR is a pure speculation play; if they don't find a $500M+ target by March 2026, investors are just getting their cash back, so watch that deadline closely.**

AI Summary

IB Acquisition Corp. (IBACR) reported no revenue or net income for the fiscal year ended September 30, 2025, as it operates as a blank check company formed to effect a business combination. The company converted to a Nevada corporation on September 21, 2023, from a Delaware entity. Its strategic outlook involves targeting high-growth companies in sectors like fintech, healthcare, sports and entertainment, and consumer goods, with an enterprise value of at least $500 million. Key risks include the inability to complete an initial business combination by the March 28, 2026 deadline, potential conflicts of interest among management, and the lack of a market for its securities. The aggregate market value of voting and non-voting common stock held by non-affiliates was $14,835,000 as of March 31, 2025, with 5,739,970 shares of common stock outstanding as of December 29, 2025.

Why It Matters

IB Acquisition Corp. (IBACR) is a SPAC with a ticking clock, aiming to merge with a high-growth company by March 28, 2026. For investors, this filing highlights the speculative nature of SPACs; success hinges entirely on finding and executing a suitable business combination. Employees and customers of a potential target company could see significant changes post-merger, including new capital access and public market exposure. In the broader market, IBACR's search for a target with an enterprise value of at least $500 million indicates potential competitive pressure in the M&A landscape, particularly in the fintech and healthcare sectors.

Risk Assessment

Risk Level: high — The risk level is high because IB Acquisition Corp. is a blank check company with no operations or revenue, and its existence is tied to completing an initial business combination by March 28, 2026. Failure to do so will result in the redemption of public shares, as stated in the 'combination period' definition. Additionally, the filing explicitly mentions 'the lack of a market for our securities' as a forward-looking risk, indicating liquidity concerns for investors.

Analyst Insight

Investors should approach IBACR with extreme caution, recognizing it as a highly speculative investment. Monitor closely for any announcements regarding a potential business combination, as this is the sole driver of value. If no suitable target is identified by the March 28, 2026 deadline, prepare for share redemption at the trust account value.

Financial Highlights

debt To Equity

N/A

revenue

$0.00

operating Margin

N/A

total Assets

N/A

total Debt

N/A

net Income

$0.00

eps

N/A

gross Margin

N/A

cash Position

N/A

revenue Growth

N/A

Key Numbers

• $14,835,000 — Aggregate market value of voting and non-voting common stock held by non-affiliates (as of March 31, 2025, indicating current market capitalization for public float)
• 5,739,970 — Shares of common stock issued and outstanding (as of December 29, 2025, representing the total shares in circulation)
• $0.0001 — Par value per share of common stock (standard par value for IBAC's common stock)
• $500 million — Minimum enterprise value for target businesses (strategic acquisition criteria for IBACR's initial business combination)
• March 28, 2026 — Deadline for completing initial business combination (critical date for IBACR's operational existence before redemption)

Key Players & Entities

• IB Acquisition Corp. (company) — registrant
• IBACR (company) — trading symbol for rights
• The NASDAQ Stock Market LLC (regulator) — exchange where securities are registered
• Adelmo "Al" Lopez (person) — Chairman and Chief Executive Officer
• Christy Albeck (person) — Chief Financial Officer
• John Joyce (person) — Vice Chairman
• Silvia Panigone (person) — Director
• Jian Zhang (person) — Director
• I-B Good Works 4, LLC (company) — sponsor

FAQ

Risk Factors

• Inability to Complete Business Combination [high — operational]: IBACR faces a critical deadline of March 28, 2026, to complete an initial business combination. Failure to do so will result in the liquidation of the company and the redemption of public shares, significantly impacting investor returns.
• Lack of Operating History and Revenue [high — financial]: As a blank check company, IBACR has no revenue or net income. Its financial performance is entirely dependent on the successful completion of a business combination, making it a speculative investment.
• Market Value Volatility [medium — financial]: The aggregate market value of IBACR's common stock held by non-affiliates was $14,835,000 as of March 31, 2025. This value is subject to significant fluctuations based on market sentiment and the perceived likelihood of a successful business combination.
• Target Business Valuation [medium — operational]: IBACR aims to acquire companies with an enterprise value of at least $500 million. The ability to identify and secure such a target at a favorable valuation is a key operational challenge.
• Potential Conflicts of Interest [medium — legal]: Management may face conflicts of interest, particularly concerning the timing and nature of any proposed business combination, which could prioritize their interests over those of public stockholders.
• Lack of Market for Securities [low — market]: There is no guarantee that a market for IBACR's securities will develop or be sustained, especially if a business combination is not consummated, which could lead to illiquidity for investors.

Industry Context

IB Acquisition Corp. operates within the Special Purpose Acquisition Company (SPAC) sector, which has seen significant activity in recent years. The company targets high-growth sectors such as fintech, healthcare, sports and entertainment, and consumer goods. These industries are characterized by rapid innovation, evolving consumer preferences, and substantial capital requirements, making them attractive for SPACs seeking to facilitate growth and liquidity for established businesses.

Regulatory Implications

As a SPAC, IBACR is subject to SEC regulations governing public companies and securities offerings. The primary regulatory risk revolves around the timely completion of a business combination to avoid liquidation, which could trigger investor redemptions and scrutiny. Compliance with disclosure requirements and potential changes in SPAC regulations are also key considerations.

What Investors Should Do

1. Monitor Business Combination Progress
2. Assess Target Company Quality
3. Understand Redemption Rights
4. Evaluate Management Team

Key Dates

• 2023-09-21: Conversion to Nevada Corporation — Changed the company's state of incorporation from Delaware to Nevada.
• 2025-03-31: Market Value Calculation — Indicated the aggregate market value of common stock held by non-affiliates was $14,835,000.
• 2025-12-29: Shares Outstanding Calculation — Reported 5,739,970 shares of common stock issued and outstanding.
• 2026-03-28: Deadline for Initial Business Combination — Critical date by which IBACR must complete a business combination or face liquidation.

Glossary

Blank Check Company

A shell corporation that is set up to acquire or merge with an existing company. It has no commercial operations and its primary purpose is to raise capital through an IPO to finance a future acquisition. (Defines IBACR's core business structure and lack of current operations.)

Business Combination

The acquisition or merger of IBACR with another company, which is the primary objective of a special purpose acquisition company (SPAC). (The central goal of IBACR's existence; failure to achieve this by the deadline has significant consequences.)

Enterprise Value

A measure of a company's total value, often used in acquisitions. It includes the market capitalization of equity, the market value of debt, and other factors. (IBACR's stated minimum target for the enterprise value of potential acquisition targets ($500 million).)

Non-affiliates

Shareholders who are not officers, directors, or major controlling shareholders of the company. (Used to calculate the public float's market value ($14,835,000 as of March 31, 2025).)

Redemption

The process by which shareholders of a SPAC can elect to have their shares repurchased by the company, typically at the initial offering price, if a business combination is not completed. (A key risk for investors if IBACR fails to meet its business combination deadline.)

Year-Over-Year Comparison

As IB Acquisition Corp. is a blank check company with no prior operating history reported in this filing, a direct comparison of financial metrics like revenue, net income, or margins to a previous year is not applicable. The key changes and focus would be on the progress made towards identifying and executing an initial business combination, the status of its cash reserves, and any updates to its strategic acquisition criteria or target industries since its formation or previous reporting periods.

Key Financial Figures

• $0.0001 — ch registered Common Stock, par value $0.0001 per share IBAC The NASDAQ Stock Mar
• $500 million — a, with an enterprise value of at least $500 million. Our Management Team and Board of Dir
• $3,000 — our founder shares for an aggregate of $3,000, or approximately $0.0009 per founder s
• $0.0009 — n aggregate of $3,000, or approximately $0.0009 per founder share. As a result of the l

Filing Documents

• form10-k.htm (10-K) — 1319KB
• ex31-1.htm (EX-31.1) — 12KB
• ex31-2.htm (EX-31.2) — 12KB
• ex32-1.htm (EX-32.1) — 7KB
• ex32-2.htm (EX-32.2) — 8KB
• 0001493152-25-029365.txt ( ) — 4774KB
• ibac-20250930.xsd (EX-101.SCH) — 33KB
• ibac-20250930_cal.xml (EX-101.CAL) — 42KB
• ibac-20250930_def.xml (EX-101.DEF) — 144KB
• ibac-20250930_lab.xml (EX-101.LAB) — 315KB
• ibac-20250930_pre.xml (EX-101.PRE) — 255KB
• form10-k_htm.xml (XML) — 473KB

Business

Business 1 Item 1A.

Risk Factors

Risk Factors 17 Item 1B. Unresolved Staff Comments 50 Item 1C Cybersecurity 50 Item 2.

Properties

Properties 50 Item 3.

Legal Proceedings

Legal Proceedings 50 Item 4. Mine Safety Disclosure 50 PART II Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 51 Item 6. [RESERVED] 52 Item 7.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 52 Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 55 Item 8. Consolidated Financial Statements and Supplementary Data 55 Item 9. Change in and Disagreements with Accountants on Accounting and Financial Disclosures 55 Item 9A.

Controls and Procedures

Controls and Procedures 55 Item 9B. Other Information 56 Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 56 PART III Item 10. Directors, Executive Officers and Corporate Governance 57 Item 11.

Executive Compensation

Executive Compensation 65 Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 66 Item 13. Certain Relationships and Related Transactions and Director Independence 67 Item 14. Principal Accountant Fees and Services 68 PART IV Item 15. Exhibits and Financial Statement Schedules 69 Item 16. Form 10-K Summary 69

Signatures

Signatures 70 i CERTAIN TERMS Unless otherwise stated in this Annual Report on Form 10-K (this "Report"), or the context otherwise requires, references to: "combination period" means the period following the completion of our initial public offering at the end of which, if we have not completed our initial business combination, we will redeem 100% of the public shares at a per share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest, divided by the number of then outstanding public shares, subject to applicable law and certain conditions and as further described herein. The combination period ends on March 28, 2026, unless we amend our charter to further extend the period of time to consummate a business combination; "founder shares" are to shares of our common stock purchased by our sponsor in a private placement prior to our initial public offering; "I-Bankers" are to I-Bankers Securities, Inc.; "initial stockholders" are to the sponsor and other direct or indirect holders of our founder shares prior to our initial public offering; "management" or our "management team" are to our executive officers and directors; "private placement rights" are to the rights issued as part of the units in a private placement to our sponsor simultaneously with the closing of our initial public offering; "private placement shares" are to the shares of common stock included in the private placement units issued to our sponsor simultaneously with the closing of our initial public offering; "public shares" are to shares of our common stock sold as part of the units in our initial public offering (whether they were purchased in our initial public offering or thereafter in the open market); "public stockholders" are to the holders of our public shares, including our sponsor and management team to the extent our sponsor and/or members of our management team purchase public shares, provided that our sponsor

Business

Business Strategy & Acquisition Criteria We intend to focus on pursuing an acquisition of or merger with high-growth companies in a number of industries including but not limited to fintech, healthcare and life sciences, sports and entertainment, and consumer goods. For owners of high-quality businesses with growth capital needs, we can be a source of non-control capital. We believe a business combination with us may provide a significant monetization event for owners desiring liquidity as well as continued equity participation for those desiring continued ownership. Further, target companies can benefit from access to a public vehicle to support organic and inorganic growth initiatives by combining with us. Our investors can benefit from ownership in a well-capitalized growth-oriented business with a highly motivated management team. Following our initial business combination, we intend to assist the target company in creating stockholder value which may include through board and/or senior management representation. As a result of our team's experience, we believe we can add value post-transaction to ensure proper corporate governance and alignment of management incentives, develop an operational and financial strategy to pursue continued organic and inorganic growth initiatives and to assist with capital raising and capital structure optimization. We will focus our search on targets seeking an investor at a discount to intrinsic value and publicly-traded peers. We have identified the following additional general criteria and guidelines that we believe are important in evaluating prospective target businesses. We intend to use these criteria and guidelines in evaluating acquisition or merger opportunities, but we may ultimately enter into our initial business combination with a company that does not meet any of these criteria and guidelines. Enterprise Value: While our ability to raise additional capital from third-parties allows us to seek a much larger bu

View Full Filing

View this 10-K filing on SEC EDGAR